Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluorohexane intratracheal instillation for smoke inhalation injury
ChiCTR-TRC-14004912Phase 4Recruiting
- Sponsor
- Characteristic Medical Center of Chinese People's Armed Police Force
- Start
- Apr 2012
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of perflexane in smoke inhalation injury (2 arms), sponsored by Characteristic Medical Center of Chinese People's Armed Police Force. Primary endpoints: Survival and quality of life, Arterial blood gas analysis and 2 more. Started Apr 2012; status: recruiting.
02
Drugs
perflexane
03
Conditions
smoke inhalation injury
Beyond the preview
Go deeper on ChiCTR-TRC-14004912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004912.